231 related articles for article (PubMed ID: 34926857)
1. Immune gene network of neurological diseases: Multiple sclerosis (MS), Alzheimer's disease (AD), Parkinson's disease (PD) and Huntington's disease (HD).
Mukherjee S
Heliyon; 2021 Dec; 7(12):e08518. PubMed ID: 34926857
[TBL] [Abstract][Full Text] [Related]
2. Integrating single-nucleus sequence profiling to reveal the transcriptional dynamics of Alzheimer's disease, Parkinson's disease, and multiple sclerosis.
Fan LY; Yang J; Liu RY; Kong Y; Guo GY; Xu YM
J Transl Med; 2023 Sep; 21(1):649. PubMed ID: 37735671
[TBL] [Abstract][Full Text] [Related]
3. Human microRNA-4433 (hsa-miR-4443) Targets 18 Genes to be a Risk Factor of Neurodegenerative Diseases.
Ge X; Yao T; Zhang C; Wang Q; Wang X; Xu LC
Curr Alzheimer Res; 2022; 19(7):511-522. PubMed ID: 35929619
[TBL] [Abstract][Full Text] [Related]
4. Common Factors in Neurodegeneration: A Meta-Study Revealing Shared Patterns on a Multi-Omics Scale.
Ruffini N; Klingenberg S; Schweiger S; Gerber S
Cells; 2020 Dec; 9(12):. PubMed ID: 33302607
[TBL] [Abstract][Full Text] [Related]
5. Shared miRNA landscapes of COVID-19 and neurodegeneration confirm neuroinflammation as an important overlapping feature.
Redenšek Trampuž S; Vogrinc D; Goričar K; Dolžan V
Front Mol Neurosci; 2023; 16():1123955. PubMed ID: 37008787
[TBL] [Abstract][Full Text] [Related]
6. Roles of long noncoding RNAs in brain development, functional diversification and neurodegenerative diseases.
Wu P; Zuo X; Deng H; Liu X; Liu L; Ji A
Brain Res Bull; 2013 Aug; 97():69-80. PubMed ID: 23756188
[TBL] [Abstract][Full Text] [Related]
7. Integrated Bioinformatics Analysis of Shared Genes, miRNA, Biological Pathways and Their Potential Role as Therapeutic Targets in Huntington's Disease Stages.
Christodoulou CC; Papanicolaou EZ
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902304
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic Orchestration of Neurodegenerative Disorders: A Possible Target for Curcumin as a Therapeutic.
Tripathi S; Bhawana
Neurochem Res; 2024 Jun; ():. PubMed ID: 38856890
[TBL] [Abstract][Full Text] [Related]
9. Large-Scale Integration of Single-Cell RNA-Seq Data Reveals Astrocyte Diversity and Transcriptomic Modules across Six Central Nervous System Disorders.
Qian Z; Qin J; Lai Y; Zhang C; Zhang X
Biomolecules; 2023 Apr; 13(4):. PubMed ID: 37189441
[TBL] [Abstract][Full Text] [Related]
10. The Immune System and Neuroinflammation as Potential Sources of Blood-Based Biomarkers for Alzheimer's Disease, Parkinson's Disease, and Huntington's Disease.
Clark LF; Kodadek T
ACS Chem Neurosci; 2016 May; 7(5):520-7. PubMed ID: 27046268
[TBL] [Abstract][Full Text] [Related]
11. Exosomes and Homeostatic Synaptic Plasticity Are Linked to Each other and to Huntington's, Parkinson's, and Other Neurodegenerative Diseases by Database-Enabled Analyses of Comprehensively Curated Datasets.
Wang JKT; Langfelder P; Horvath S; Palazzolo MJ
Front Neurosci; 2017; 11():149. PubMed ID: 28611571
[TBL] [Abstract][Full Text] [Related]
12. Cognitive performance in healthy clinical trial participants and patients with the NeuroCart, a neurodegenerative disease measured with an automated neuropsychological and neurophysiological test battery.
Prins S; Borghans L; de Kam ML; Groeneveld GJ; van Gerven J
J Neurol Sci; 2023 Jun; 449():120658. PubMed ID: 37079973
[TBL] [Abstract][Full Text] [Related]
13. Evidence for a Pan-Neurodegenerative Disease Response in Huntington's and Parkinson's Disease Expression Profiles.
Labadorf A; Choi SH; Myers RH
Front Mol Neurosci; 2017; 10():430. PubMed ID: 29375298
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of colony stimulating factor-1 receptor (CSF-1R) as a potential therapeutic strategy for neurodegenerative diseases: opportunities and challenges.
Han J; Chitu V; Stanley ER; Wszolek ZK; Karrenbauer VD; Harris RA
Cell Mol Life Sci; 2022 Apr; 79(4):219. PubMed ID: 35366105
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA (miRNA) as a biomarker for diagnosis, prognosis, and therapeutics molecules in neurodegenerative disease.
Alkhazaali-Ali Z; Sahab-Negah S; Boroumand AR; Tavakol-Afshari J
Biomed Pharmacother; 2024 Jun; 177():116899. PubMed ID: 38889636
[TBL] [Abstract][Full Text] [Related]
16. A Microglial Signature Directing Human Aging and Neurodegeneration-Related Gene Networks.
Mukherjee S; Klaus C; Pricop-Jeckstadt M; Miller JA; Struebing FL
Front Neurosci; 2019; 13():2. PubMed ID: 30733664
[TBL] [Abstract][Full Text] [Related]
17. TYROBP/DAP12 knockout in Huntington's disease Q175 mice cell-autonomously decreases microglial expression of disease-associated genes and non-cell-autonomously mitigates astrogliosis and motor deterioration.
Creus-Muncunill J; Haure-Mirande JV; Mattei D; Bons J; Ramirez AV; Hamilton BW; Corwin C; Chowdhury S; Schilling B; Ellerby LM; Ehrlich ME
J Neuroinflammation; 2024 Mar; 21(1):66. PubMed ID: 38459557
[TBL] [Abstract][Full Text] [Related]
18. Orexinergic System in Neurodegenerative Diseases.
Wang Q; Cao F; Wu Y
Front Aging Neurosci; 2021; 13():713201. PubMed ID: 34483883
[TBL] [Abstract][Full Text] [Related]
19. Cross-Talking Pathways of Forkhead Box O1 (FOXO1) Are Involved in the Pathogenesis of Alzheimer's Disease and Huntington's Disease.
Liu L; Bai J; Liu F; Xu Y; Zhao M; Zhao C; Zhou Z
Oxid Med Cell Longev; 2022; 2022():7619255. PubMed ID: 35154571
[TBL] [Abstract][Full Text] [Related]
20. Identifying the hub gene and immune infiltration of Parkinson's disease using bioinformatical methods.
Liu SH; Wang YL; Jiang SM; Wan XJ; Yan JH; Liu CF
Brain Res; 2022 Jun; 1785():147879. PubMed ID: 35278479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
